- Home
- IMNM vs PDO Comparison
IMNM vs PDO Comparison
Compare IMNM & PDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMNM | PDO |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | IMNM | PDO |
|---|---|---|
| Price | $24.04 | $14.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $31.22 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 520.0K |
| Earning Date | 03-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,679,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.53 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.15 | $10.65 |
| 52 Week High | $27.65 | $13.31 |
Technical Indicators
Market Signals| Indicator | IMNM | PDO |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 60.07 |
| Support Level | $23.86 | $14.01 |
| Resistance Level | $27.65 | $14.06 |
| Average True Range (ATR) | 1.63 | 0.06 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 62.94 | 94.74 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest
PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.